Effectiveness of Intrarectal Povidone-iodine Cleansing Plus Formalin Disinfection of the Needle Tip in Decreasing Infectious Complications After Transrectal Prostate Biopsy: A Randomized Controlled Trial
Nenhuma Miniatura disponível
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
FREIRE, Tiago Magalhaes
PUGLIESI, Felipe Guimaraes
COSTA, Felipe Machado de Moura
SOUZA, Vinicius Meneguette Gomes De
ALBERTINI, Aline
COUTO, Adriano Borba
Citação
JOURNAL OF UROLOGY, v.208, n.6, p.1194-1202, 2022
Resumo
Purpose:Prostate biopsy is mostly performed through the transrectal route worldwide and infectious complications may occur in up to 7% of cases. Therefore, alternative strategies to decrease infectious complications are needed. Our aim was to evaluate the effectiveness of intrarectal povidone-iodine cleansing plus formalin disinfection of the needle tip in decreasing infectious complications after transrectal ultrasound guided prostate biopsy.Materials and Methods:We conducted a prospective, single-center, phase III trial in patients undergoing transrectal ultrasound guided prostate biopsy randomized 1:1 to rectal mucosa cleansing with gauze soaked in 10% povidone-iodine solution wrapped around the gloved index finger and needle tip disinfection by immersion in a 10% formalin solution before each puncture vs control group. The primary end point was the rate of infectious complications defined as 1 or more of the following events: fever, urinary tract infection, or sepsis.Results:Overall, 633 patients were randomized to the intervention group and 623 to the control group. The infectious complication rate was 3.9% in the intervention group and 6.4% in the control group (RR 0.61; 95% CI 0.36-0.99; P = .049). The rates of sepsis, urinary tract infection, and fever were 0.3% vs 0.5% (P = .646), 2.3% vs 4.1% (P = .071), and 1.3% vs 1.9% (P = .443), respectively. The positive urine culture rate was 5.2% in the intervention group and 9% in the control group (RR 0.57; P = .015). There was no statistically significant difference between the groups regarding the occurrence of noninfectious adverse events.Conclusions:Intrarectal povidone-iodine cleansing plus formalin disinfection of the biopsy needle tip was associated with a reduction in infectious complications after transrectal prostate biopsy.
Palavras-chave
sepsis, urinary tract infections, biopsy, complications
Referências
- AbuGhosh Z, 2013, J UROLOGY, V189, P1326, DOI 10.1016/j.juro.2012.09.121
- Aly M, 2015, PROSTATE, V75, P947, DOI 10.1002/pros.22979
- Auffenberg GB, 2018, BJU INT, V121, P232, DOI 10.1111/bju.13982
- Bonkat G, 2019, EAU ANN C
- Borghesi M, 2017, EUR UROL, V71, P353, DOI 10.1016/j.eururo.2016.08.004
- Chow S-C, 2003, SAMPLE SIZE CALCULAT, V1st, DOI 10.1201/9780203911341
- Derin O, 2020, WORLD J UROL, V38, P2743, DOI 10.1007/s00345-020-03112-3
- Gonzalez CM., AUA SUNA WHITE PAPER
- Issa MM, 2013, J UROLOGY, V190, P1769, DOI 10.1016/j.juro.2013.04.134
- Jazayeri SB, 2020, UROLOGY, V144, P21, DOI 10.1016/j.urology.2020.06.005
- Johansen TEB, 2020, WORLD J UROL, V38, P17, DOI 10.1007/s00345-019-02837-0
- Lange D, 2009, UROLOGY, V74, P1200, DOI 10.1016/j.urology.2009.07.1222
- Liss MA, 2014, J UROLOGY, V192, P1673, DOI 10.1016/j.juro.2014.06.005
- Loeb S, 2013, EUR UROL, V64, P876, DOI 10.1016/j.eururo.2013.05.049
- Loeb S, 2011, J UROLOGY, V186, P1830, DOI 10.1016/j.juro.2011.06.057
- Mottet N, 2022, EAU ANN C AMST
- Nam RK, 2013, J UROLOGY, V189, pS12, DOI 10.1016/j.juro.2012.11.015
- Pilatz A, 2020, J UROLOGY, V204, P224, DOI 10.1097/JU.0000000000000814
- Pilatz A, 2021, EUR UROL, V79, P11, DOI 10.1016/j.eururo.2020.10.019
- Pilatz A, 2019, EUR UROL FOCUS, V5, P20, DOI 10.1016/j.euf.2018.11.009
- Pontes J, 2017, J UROLOGY, V197, pE484, DOI 10.1016/j.juro.2017.02.1154
- Pradere B, 2021, J UROLOGY, V205, P653, DOI 10.1097/JU.0000000000001399
- Roberts MJ, 2017, UROLOGY, V104, P11, DOI 10.1016/j.urology.2016.12.011
- Scott S, 2018, WORLD J UROL, V36, P1007, DOI 10.1007/s00345-018-2217-7
- Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287
- Singla N, 2017, PROSTATE CANCER P D, V20, P216, DOI 10.1038/pcan.2016.70
- Teillant A, 2015, LANCET INFECT DIS, V15, P1429, DOI 10.1016/S1473-3099(15)00270-4
- Xiang JJ, 2019, WORLD J SURG ONCOL, V17, DOI 10.1186/s12957-019-1573-0
- Zani EL, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006576.pub2
- Zaytoun OM, 2011, UROLOGY, V77, P910, DOI 10.1016/j.urology.2010.12.033